Prevalence of eating disorders: a comparison of Western and non-Western countriesStandards for clinical trials in sexual dysfunction in women: research designs and outcomes assessment.Menstrual diary data and menopausal transition: methodologic issues.Predictive Factors for Verbal Memory Performance Over Decades of Aging: Data from the Women's Healthy Ageing Project.Unhealthy habits persist: The ongoing presence of modifiable risk factors for disease in womenA prospective study of the association between endogenous hormones and depressive symptoms in postmenopausal womenTowards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensusThe ageing female reproductive axis I.Estrogen and androgen hormone therapy and well-being in surgically postmenopausal women.Perimenopausal use of hormone therapy is associated with enhanced memory and hippocampal function later in life.Hormonal changes in the menopause transition.The menopause and sexual functioning: a review of the population-based studies.Evaluation of four proposed bleeding criteria for the onset of late menopausal transition.The effects of postmenopausal hormone therapies on female sexual functioning: a review of double-blind, randomized controlled trials.Sexuality.Confronting the challenges: epidemiological study of female sexual dysfunction and the menopause.The impact of aging on sexual function and sexual dysfunction in women: a review of population-based studies.What can prevalence studies tell us about female sexual difficulty and dysfunction?Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies.The unique challenges of managing depression in mid-life womenAre aspects of study design associated with the reported prevalence of female sexual difficulties?Treatment of vasomotor symptoms in the menopausal transition and postmenopausally: psychiatric comorbidity.Assessment and treatment for insomnia and fatigue in the symptomatic menopausal woman with psychiatric comorbidity.Arthralgias, bodily aches and pains and somatic complaints in midlife women: etiology, pathophysiology and differential diagnosis.Role of psychiatric comorbidity on cognitive function during and after the menopausal transition.Impact of clinician and patient attitudes on clinical decision making for the symptomatic menopausal woman with or without comorbidity.Series overview and introduction.Nomenclature and endocrinology of menopause and perimenopause.Women, anxiety and mood: a review of nomenclature, comorbidity and epidemiology.Neurobehavioral impact of menopause on mood.Role of stressful life events and menopausal stage in wellbeing and health.The frequency of sexual intercourse reported by women: a review of community-based studies and factors limiting their conclusions.Testosterone and libido in surgically and naturally menopausal women.ISPMD consensus on the management of premenstrual disorders.Diagnosis and management of premenstrual disorders.Epidemiology of premenstrual symptoms and disorders.Clinical subtypes of core premenstrual disorders: a Delphi survey.The Women's Healthy Ageing Project: fertile ground for investigation of healthy participants 'at risk' for dementia.The value of follicle-stimulating hormone concentration and clinical findings as markers of the late menopausal transition.Hormone levels and cognitive function in postmenopausal midlife women.
P50
Q24548221-C2135C42-0797-4818-8C8C-015FAA343C47Q30449979-DB0F6D13-4F37-4523-BC69-3AB9EB6B0BA0Q30715800-836CBF10-3A72-476D-91C3-A32ED04D771DQ31123695-169F3A6E-5C35-429B-A6E6-BDE07CB2C8B4Q33558673-B79C01B2-21AB-4A02-80E2-A2DC66F20F9EQ33622200-8528162B-310C-4AD9-A3C8-543236DB24BBQ34053506-54C212B9-A66D-40C5-AB34-CB46340CA81DQ34539000-F3DDC473-7DFC-4AA9-9E3A-122704F0AC81Q34579568-87CE2CAF-6A7B-4412-B0B2-B88005FC3684Q34612271-F53E48D1-1595-498F-8C7A-1DCE9AD9C5FAQ34644005-305B7ED3-51FB-4F1F-863A-1829DC840796Q35852449-4730A228-8BE6-4DC2-A0C4-2F6016E909D4Q35945927-8436ADBB-E417-4A22-BEBF-20DB2E6788F7Q35948939-BBCAB52C-63CE-47A5-8108-B0B47BCA8FDDQ36369121-9DEEF3EE-B401-48D3-9A2B-1A1C19457A36Q36372367-E33B9822-7F98-43A4-A93B-465A761DEF59Q36372433-2C81A2C6-6C12-48FA-8870-2AC5FE178ECEQ36535137-2C7EDD91-24ED-44AD-8547-F4AD4A1DD4CEQ36799602-1CFB1E94-2CE7-4BD4-973A-BA04A891BC1AQ36919943-D8ED07FE-4D2C-4EEC-9E7B-80C250FBCACCQ36991170-D5C41CF6-DACF-4B51-A9C9-ED173B4A899EQ37014593-CBD5AA6B-1C48-41D4-A192-C95AB3869B99Q37014597-856133E0-28DE-4940-9859-E0CDFFC90F4DQ37014601-CAE14EC2-4FFB-4ACF-BE3E-77B12FF3A880Q37014605-9E197F8A-A38B-46BD-9958-0ED548D6EFF0Q37014609-93C5DBB4-C783-4B9D-81A9-08C9D48BED27Q37014613-64976EA6-899C-412E-9E91-E84D6D91104DQ37014618-E276CC37-08F6-4F34-A2C8-E1A6C0EDA8F0Q37014621-AE04E5D9-10E5-406C-8D1A-22217BB9838AQ37014639-D3885779-F90B-430E-9BE3-EEF9A2CDB614Q37014645-E347F913-8BC9-449D-A36B-1D317BFE44E4Q37034452-A2FBB09E-84C6-4D12-BD90-18A2C3830D76Q37608368-6DD5028B-140C-4FFC-B1AD-79D410BEDD62Q37638987-DC302BCA-4EE6-43F2-A607-0677E340558FQ37885076-AF401DC4-E03E-4195-9C3F-8CBCC2A2577CQ38011684-0BB8C862-C35E-4EFD-B2A8-D39B8D130F6BQ38071915-5F28717A-B8BC-46EF-9CBF-C233235B4547Q38178374-813BA739-61CF-406C-882B-E82FC1B73CD1Q38468232-9731BE2D-A956-4138-8F70-E2A93DB420E6Q38471396-3954470E-66E9-435D-B122-BFC2E47D60DF
P50
description
Australian scientist
@en
Australian scientist
@en-ca
Australian scientist
@en-gb
academisch docent
@nl
aŭstralia sciencisto
@eo
científica australiana
@es
nolavan Laustralänik
@vo
siensiste australian
@lfn
عالمة أسترالية
@ar
name
Lorraine Dennerstein
@ast
Lorraine Dennerstein
@en
Lorraine Dennerstein
@es
Lorraine Dennerstein
@nl
type
label
Lorraine Dennerstein
@ast
Lorraine Dennerstein
@en
Lorraine Dennerstein
@es
Lorraine Dennerstein
@nl
altLabel
L. Dennerstein
@en
L. Dennerstein
@nl
prefLabel
Lorraine Dennerstein
@ast
Lorraine Dennerstein
@en
Lorraine Dennerstein
@es
Lorraine Dennerstein
@nl
P1006
P1006
P21
P31
P4228
P569
1947-08-05T00:00:00Z